Tadalafil and Vision Problems: Eye Side Effects Explained

• Online consultation with UK-registered prescribers who check your eye and vascular health history first
• Clear, accurate information on the genuine risks, neither exaggerated nor dismissed
• Straightforward guidance on exactly what to do if sudden vision changes happen
• Ongoing prescriber support if you have any concerns about your treatment

Tadalafil has a reported association with a condition called non-arteritic anterior ischaemic optic neuropathy (NAION), which can cause sudden, usually painless, vision loss in one eye and may sometimes be permanent. The available evidence does not allow the frequency of NAION with tadalafil to be estimated reliably, but UK product information specifically warns about the possibility.

For men aged 18 and over in the UK who are considering tadalafil or already using it, especially anyone who wants clear guidance on eye health and medication safety, this guide explains what NAION actually is, how it relates to tadalafil, how it differs from other, milder visual side effects, which risk factors matter, what checks a prescriber may consider before treatment, and exactly what to do if you notice a sudden change in your vision. Understanding these points helps you use tadalafil tablets more safely, recognise a serious side effect quickly, and have an informed conversation with a healthcare professional if anything changes.

Can Tadalafil Cause Vision Loss?

Yes,there is a reported association. Tadalafil has a recognised, reported association with a condition called non-arteritic anterior ischaemic optic neuropathy, known as NAION, which can cause sudden vision loss. This is not a common side effect, and most people taking tadalafil never experience any problem with their vision at all. The important practical point is that sudden visual defects, reduced visual acuity or visual distortion while taking tadalafil should be treated seriously: the UK product information advises stopping tadalafil and consulting a doctor immediately.

What Is NAION?

NAION stands for non-arteritic anterior ischaemic optic neuropathy. It is a condition affecting the optic nerve that can cause sudden, usually painless loss or reduction of vision in one eye.

NAION is not specific to tadalafil or PDE5 inhibitors and can occur independently of these medicines. The UK product information states that cases of NAION have been reported in connection with tadalafil and other PDE5 inhibitors, while observational data suggest an increased risk following exposure. This is an association rather than proof that tadalafil directly causes every case.

What NAION Actually Feels Like

NAION typically presents as a sudden change noticed on waking, or as blurred vision, dimming, or partial loss of vision in one eye, usually without any pain. It is genuinely different from a gradual change you might put down to tiredness or normal eye strain, the defining feature is how sudden and one-sided it is. This is exactly why any sudden visual change, however it feels, deserves urgent attention rather than a wait-and-see approach.

Can Tadalafil Cause Permanent Blindness?

This is worth answering precisely, because the honest answer is more specific than a simple yes or no. NAION typically affects one eye, not both, and it is not the same thing as total or complete blindness. However, the vision loss it causes in the affected eye can be permanent, it does not always resolve on its own. So while "permanent total blindness" overstates what NAION usually involves, "permanent vision loss in one eye" is an accurate description of the genuine, though rare, risk being described.

How Common Is This, Really?

NAION is an uncommon eye condition, but its frequency specifically among tadalafil users cannot be estimated reliably from the available evidence. The UK product information therefore lists NAION as an adverse event for which the frequency is not known.

Observational research involving PDE5 inhibitors as a group has suggested an approximately two-fold increase in the risk of acute NAION shortly after exposure. However, observational studies can show an association without proving that the medicine itself caused the condition.

More recently, a large 2026 multinational observational study examined tadalafil use in men with lower urinary tract symptoms. It found an association between tadalafil use and glaucoma, with a hazard ratio of 1.22 compared with non-PDE5 inhibitor use. The study was observational, so these findings do not establish that tadalafil directly causes glaucoma.

Taken together, the evidence supports taking new visual symptoms seriously without suggesting that serious eye problems are an expected outcome of tadalafil treatment.

Putting the Numbers in Context

Even accounting for this observed association, NAION remains a rare event overall. The great majority of men who take tadalafil, including those with some of the risk factors described below, never develop NAION. This context matters, because a rare but genuine risk is very different from a common one, and it is important not to lose sight of that while still taking the warning seriously.

Does This Mean Tadalafil is not Safe?

Understanding a rare risk properly is different from concluding a medicine generally is not safe. Tadalafil remains a licensed, widely used medicine, and this specific risk is disclosed precisely so the potential risks and potential side effects can be weighed up honestly against the expected benefit during a proper clinical assessment, rather than discovered only after something goes wrong. Whether tadalafil is a reasonable option for you specifically is a conversation to have with a prescriber, informed by your own health history, not a decision to make from a place of general alarm or from search results alone.

Who Is More at Risk?

Certain underlying factors are more commonly seen in people who have developed NAION, whether or not they were taking a PDE5 inhibitor at the time.

Recognised Risk Factors

• Age over 50
• Diabetes
• Diabetic retinopathy may further increase the risk of vision problems with tadalafil because it already affects the blood vessels in the retina.
• High blood pressure
• Heart disease
• High cholesterol
• Smoking
• A particular eye anatomy sometimes described as a "crowded disc", where there is less space around the optic nerve

Most, but not all, people who have developed NAION in connection with PDE5 inhibitor use had one or more of these underlying factors already. This is exactly the kind of medical history, including other conditions and underlying conditions that can affect eye risk, a proper clinical assessment is designed to identify before tadalafil is prescribed.

Other Visual Side Effects: Not Just NAION

NAION is not the only eye-related effect that has been reported with tadalafil, and it is worth understanding how the others differ. For regular users of tadalafil, especially with ongoing use, regular eye checks may be worth discussing with a clinician. Ongoing eye health monitoring can improve treatment outcomes by helping eye problems and visual effects get recognised earlier.

Central Serous Chorioretinopathy (CSCR)

CSCR is a condition involving fluid building up beneath the retina, which has also been reported in connection with tadalafil and other PDE5 inhibitors. Unlike NAION, most reported cases of CSCR resolved on their own after stopping tadalafil, making it a meaningfully different, generally more reversible concern, though it is still worth mentioning any noticeable visual change to a prescriber rather than assuming it will simply pass.

Mild, More Common Visual Changes

Separately from these rarer, more serious conditions, tadalafil is associated with a lower rate of mild visual disturbances, such as a blue tinge to vision, compared with some other PDE5 inhibitors, but mild changes should not be ignored if they persist beyond 24 to 36 hours. This kind of mild change is a different category of side effect entirely from NAION or CSCR, generally temporary and not a sign of the same underlying process, but persistent visual problems lasting over 24-36 hours still need medical attention even if they seem mild at first.

What to Do If You Notice Sudden Vision Changes

If you experience any sudden visual defect, loss of vision, or visual distortion while taking tadalafil, act on it straight away rather than waiting to see if it passes.

Immediate Steps

1. Stop taking tadalafil as soon as you notice any sudden change in your vision.
2. Seek medical attention immediately and contact a doctor immediately, rather than waiting to see if it improves on its own.
3. Describe exactly what you have noticed, including which eye is affected, when it started, and whether it is changed since.
4. Tell them you have been taking tadalafil, and roughly when you last took it.

Sudden loss of vision should be treated as an emergency because there are several potentially serious causes, including NAION.

Sudden vision loss is always worth treating as urgent, whatever the eventual cause turns out to be. This is not a symptom to monitor at home and see if it settles.

Who Should Not Take Tadalafil Because of Eye History

Tadalafil is not prescribed to anyone with a personal history of vision loss in one eye due to NAION, regardless of whether that previous episode happened in connection with a PDE5 inhibitor or not. This is a firm contraindication in UK product information, reflecting a meaningfully higher risk of recurrence in someone who has already had one episode. If this applies to you, a prescriber will not offer tadalafil, and this is not a rule to try to work around, since the underlying concern is genuinely about protecting your remaining vision.

This applies even if the previous NAION episode was not connected to a PDE5 inhibitor at all. The contraindication is based on the underlying vulnerability the condition represents, not on assuming a previous medicine caused it. Tadalafil is also not generally recommended in patients with hereditary degenerative retinal disorders such as retinitis pigmentosa because safety data are limited.

How This Is Screened For Before Prescribing

Before prescribing tadalafil, a healthcare professional should review the person's medical history, current medicines and relevant cardiovascular and eye history.

This may include asking about previous NAION or other significant eye problems, as well as conditions such as diabetes, high blood pressure and cardiovascular disease. The assessment also considers medicines that can affect whether tadalafil is suitable, including certain alpha-blockers.

The purpose is not to predict with certainty who will develop an eye problem. Rather, it helps the prescriber identify contraindications, relevant risk factors and situations where tadalafil may not be appropriate.

Medical Disclaimer

This article is for general information only and does not replace individual medical advice. Tadalafil is a prescription-only medicine and should only be taken under the guidance of appropriately qualified healthcare professionals, following a proper clinical assessment that considers your individual risk factors, people prescribed tadalafil on an ongoing basis should also have annual medication reviews, especially if risk factors or visual symptoms change. Results and side effects vary between individuals. If you experience any sudden change in vision, including loss of vision, visual distortion, or a sudden change in one or both eyes, stop taking tadalafil and seek urgent medical attention immediately, go to A&E or call 999. This article does not constitute medical advice and should not be used to self-diagnose or self-treat.